Search alternatives:
better decrease » greater decrease (Expand Search), teer decrease (Expand Search), between decreased (Expand Search)
between treated » between trace (Expand Search), between predicted (Expand Search), between estimated (Expand Search)
higher decrease » higher degree (Expand Search), higher degrees (Expand Search), highest increase (Expand Search)
better decrease » greater decrease (Expand Search), teer decrease (Expand Search), between decreased (Expand Search)
between treated » between trace (Expand Search), between predicted (Expand Search), between estimated (Expand Search)
higher decrease » higher degree (Expand Search), higher degrees (Expand Search), highest increase (Expand Search)
-
141
-
142
-
143
-
144
-
145
-
146
AO/EtBr Staining of Cancer cell lines: <i>To check whether vitamin D3 promoted cell death in cancer cells, a dual staining protocol was implemented as detailed in the methods secti...
Published 2025“…The data represents the mean of at least 3 different fields. Differences between control and vitamin D3 treated groups were calculated and the level of significance was assessed by GraphPad Prism. …”
-
147
-
148
-
149
-
150
RNA sequencing analysis of EV-treated LECs.
Published 2025“…(D) Comparisons of expression levels of genes related to stemness, differentiation, and epithelial-mesenchymal transition (EMT) between the control and EV-treated groups. <i>n</i> = 3 biological replicates. …”
-
151
Association between CTI and CVD.
Published 2025“…</p><p>Conclusion</p><p>Higher CTI (whether treated as a continuous or categorical variable) was significantly associated with an increased risk of CVD. …”
-
152
Data Sheet 1_Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab.docx
Published 2024“…This study explored the association between PD-L1 expression in TME and outcomes in HCC patients treated with atezolizumab plus bevacizumab (AB), emphasizing the implications of PD-L1 expression in both malignant and tumor-infiltrating cells.…”
-
153
-
154
-
155
-
156
-
157
-
158
-
159
-
160
S1 Data -
Published 2024“…Comparing to patients whose longitudinal trajectory of blood glucose conformed to class 1, those with class 2 (HR = 2.52, 95%CI: 1.79–3.53) or class 4 (HR = 3.53, 95%CI: 2.07–6.03) seemed to have higher risk of 30-day mortality. Additionally, these associations were also significant in aged ≥60 years old, female, male, NSTEMI, and STEMI subgroups (all <i>P</i><0.05).…”